Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Human CD300a/LMIR1 Fc Chimera Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Supplier: R&D Systems™ 2640LM050
This item is not returnable.
View return policy
Description
The Recombinant Human CD300a/LMIR1 Fc Chimera Protein is derived from NS0. The Recombinant Human CD300a/LMIR1 Fc Chimera Protein has been validated for the following applications: Bioactivity.Specifications
| Lyophilized from a 0.2μm filtered solution in PBS. | |
| 44.0 kDa (monomer) | |
| 90%, by SDS-PAGE under reducing conditions and visualized by silver stain. | |
| Mouse myeloma cell line,NS0-derived human CD300a/LMIR1 protein, (N-terminus) Human CD300a (Leu18-Gln178) Accession &Num; Q9UGN4 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) | |
| Disulfide-linked homodimer | |
| Yes |
| 11314 | |
| CD300a/LMIR1 Fc Chimera | |
| 50μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title